 |
Previous Article | Next Article 
The Journal of Neuroscience, September 1, 1999, 19(17):7486-7494
cAMP-Dependent Protein Kinase Phosphorylations on Tau in
Alzheimer's Disease
Gregory A.
Jicha1,
Charles
Weaver2,
Eric
Lane1,
Cintia
Vianna1,
Yvonne
Kress1,
Julia
Rockwood1, and
Peter
Davies1, 2
Departments of 1 Pathology and
2 Neuroscience, Albert Einstein College of Medicine, Bronx,
New York 10461
To elucidate the role cAMP-dependent protein kinase (PKA)
phosphorylations on tau play in Alzheimer's disease, we have generated highly specific monoclonal antibodies, CP-3 and PG-5, which
recognize the PKA-dependent phosphorylations of ser214 and ser409 in
tau respectively. The present study demonstrates by immunohistochemical analysis, CP-3 and PG-5 immunoreactivity with neurofibrillary pathology
in both early and advanced Alzheimer's disease, but not in normal
brain tissue and demonstrates that cAMP-dependent protein kinase
phosphorylations on tau precede or are coincident with the initial
appearance of filamentous aggregates of tau. Studies using heat-stable
preparations demonstrate that neither site appears to be phosphorylated
to any appreciable extent in normal rodent or human brain. Further
analysis demonstrates that the catalytic subunit of PKA (C ), the
II regulatory subunit of PKA (RII ), and the 79 kDa
A-kinase-anchoring-protein (AKAP79), are tightly associated with the
neurofibrillary pathology, positioning cAMP-dependent protein kinase to
participate directly in the pathological hyperphosphorylation of tau
seen in Alzheimer's disease.
Key words:
tau; Alzheimer's disease; protein kinase; cAMP; phosphorylation; neurofibrillary pathology
Copyright © 1999 Society for Neuroscience 0270-6474/99/19177486-09$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
D. Han, H. Y. Qureshi, Y. Lu, and H. K. Paudel
Familial FTDP-17 Missense Mutations Inhibit Microtubule Assembly-promoting Activity of Tau by Increasing Phosphorylation at Ser202 in Vitro
J. Biol. Chem.,
May 15, 2009;
284(20):
13422 - 13433.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Abdi, M. B. Tahoori, and E. S. Emamian
Fault Diagnosis Engineering of Digital Circuits Can Identify Vulnerable Molecules in Complex Cellular Pathways
Sci. Signal.,
October 21, 2008;
1(42):
ra10 - ra10.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. S. Liang, T. Dunckley, T. G. Beach, A. Grover, D. Mastroeni, K. Ramsey, R. J. Caselli, W. A. Kukull, D. McKeel, J. C. Morris, et al.
Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set
Physiol Genomics,
April 1, 2008;
33(2):
240 - 256.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Creighton, B. Zhu, M. Alexeyev, and T. Stevens
Spectrin-anchored phosphodiesterase 4D4 restricts cAMP from disrupting microtubules and inducing endothelial cell gap formation
J. Cell Sci.,
January 1, 2008;
121(1):
110 - 119.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Steinhilb, D. Dias-Santagata, T. A. Fulga, D. L. Felch, and M. B. Feany
Tau Phosphorylation Sites Work in Concert to Promote Neurotoxicity In Vivo
Mol. Biol. Cell,
December 1, 2007;
18(12):
5060 - 5068.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. L. Spires, J. D. Orne, K. SantaCruz, R. Pitstick, G. A. Carlson, K. H. Ashe, and B. T. Hyman
Region-specific Dissociation of Neuronal Loss and Neurofibrillary Pathology in a Mouse Model of Tauopathy
Am. J. Pathol.,
May 1, 2006;
168(5):
1598 - 1607.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Lambourne, L. A. Sellers, T. G. Bush, S. K. Choudhury, P. C. Emson, Y.-H. Suh, and L. S. Wilkinson
Increased tau Phosphorylation on Mitogen-Activated Protein Kinase Consensus Sites and Cognitive Decline in Transgenic Models for Alzheimer's Disease and FTDP-17: Evidence for Distinct Molecular Processes Underlying tau Abnormalities
Mol. Cell. Biol.,
January 1, 2005;
25(1):
278 - 293.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Liu, J. Y. Zhang, H. L. Li, Z. Y. Fang, Q. Wang, H. M. Deng, C. X. Gong, I. Grundke-Iqbal, K. Iqbal, and J. Z. Wang
Tau Becomes a More Favorable Substrate for GSK-3 When It Is Prephosphorylated by PKA in Rat Brain
J. Biol. Chem.,
November 26, 2004;
279(48):
50078 - 50088.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Fath, J. Eidenmuller, and R. Brandt
Tau-Mediated Cytotoxicity in a Pseudohyperphosphorylation Model of Alzheimer's Disease
J. Neurosci.,
November 15, 2002;
22(22):
9733 - 9741.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Allen, E. Ingram, M. Takao, M. J. Smith, R. Jakes, K. Virdee, H. Yoshida, M. Holzer, M. Craxton, P. C. Emson, et al.
Abundant Tau Filaments and Nonapoptotic Neurodegeneration in Transgenic Mice Expressing Human P301S Tau Protein
J. Neurosci.,
November 1, 2002;
22(21):
9340 - 9351.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Conrad, C. Vianna, M. Freeman, and P. Davies
A polymorphic gene nested within an intron of the tau gene: Implications for Alzheimer's disease
PNAS,
May 28, 2002;
99(11):
7751 - 7756.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Lewis, D. W. Dickson, W.-L. Lin, L. Chisholm, A. Corral, G. Jones, S.-H. Yen, N. Sahara, L. Skipper, D. Yager, et al.
Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP
Science,
August 24, 2001;
293(5534):
1487 - 1491.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Bi, A. P. Yong, J. Zhou, C. E. Ribak, and G. Lynch
Rapid induction of intraneuronal neurofibrillary tangles in apolipoprotein E-deficient mice
PNAS,
June 28, 2001;
(2001)
151253098.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. C. Foster, K. M. Sharrow, J. R. Masse, C. M. Norris, and A. Kumar
Calcineurin Links Ca2+ Dysregulation with Brain Aging
J. Neurosci.,
June 1, 2001;
21(11):
4066 - 4073.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. B. Lester, M. C. Faux, J. B. Nauert, and J. D. Scott
Targeted Protein Kinase A and PP-2B Regulate Insulin Secretion through Reversible Phosphorylation
Endocrinology,
March 1, 2001;
142(3):
1218 - 1227.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Shanavas and S. Ch. Papasozomenos
tau kinases in the rat heat shock model: Possible implications for Alzheimer disease
PNAS,
December 19, 2000;
97(26):
14139 - 14144.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-X. Gong, T. Lidsky, J. Wegiel, L. Zuck, I. Grundke-Iqbal, and K. Iqbal
Phosphorylation of Microtubule-associated Protein Tau Is Regulated by Protein Phosphatase 2A in Mammalian Brain. IMPLICATIONS FOR NEUROFIBRILLARY DEGENERATION IN ALZHEIMER'S DISEASE
J. Biol. Chem.,
February 25, 2000;
275(8):
5535 - 5544.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hashiguchi, K. Sobue, and H. K. Paudel
14-3-3zeta Is an Effector of Tau Protein Phosphorylation
J. Biol. Chem.,
August 11, 2000;
275(33):
25247 - 25254.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Bi, A. P. Yong, J. Zhou, C. E. Ribak, and G. Lynch
Rapid induction of intraneuronal neurofibrillary tangles in apolipoprotein E-deficient mice
PNAS,
July 17, 2001;
98(15):
8832 - 8837.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|